Effects of Intra-aortic Balloon Pump on In-hospital Outcomes and 1-year Mortality in Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock

Overview

Journal BMC Cardiovasc Disord

Publisher Biomed Central

Specialty Cardiology & Vascular Diseases

Date 2023 Aug 29

PMID 37644466

Authors

Dingfeng Fang

Dongdong Yu

Jiabin Xu

Wei Ma

Yuxiang Zhong

Haibo Chen

Affiliations

Soon will be listed here.

Abstract

Background: The role of intra-aortic balloon counterpulsation (IABP) in cardiogenic shock complicating acute myocardial infarction (AMI) is still a subject of intense debate. In this study, we aim to investigate the effect of IABP on the clinical outcomes of patients with AMI complicated by cardiogenic shock undergoing percutaneous coronary intervention (PCI).

Methods: From the Medical Information Mart for Intensive Care (MIMIC)-IV 2.2, 6017 AMI patients were subtracted, and 250 patients with AMI complicated by cardiogenic shock undergoing PCI were analyzed. In-hospital outcomes (death, 24-hour urine volumes, length of ICU stays, and length of hospital stays) and 1-year mortality were compared between IABP and control during the hospital course and 12-month follow-up.

Results: An IABP was implanted in 30.8% (77/250) of patients with infarct-related cardiogenic shock undergoing PCI. IABP patients had higher levels of Troponin T (3.94 [0.73-11.85] ng/ml vs. 1.99 [0.55-5.75] ng/ml, p-value = 0.02). IABP patients have a longer length of ICU and hospital stays (124 [63-212] hours vs. 83 [43-163] hours, p-value = 0.005; 250 [128-435] hours vs. 170 [86-294] hours, p-value = 0.009). IABP use was not associated with lower in-hospital mortality (33.8% vs. 33.0%, p-value = 0.90) and increased 24-hour urine volumes (2100 [1455-3208] ml vs. 1915 [1110-2815] ml, p-value = 0.25). In addition, 1-year mortality was not different between the IABP and the control group (48.1% vs. 48.0%; hazard ratio 1.04, 95% CI 0.70-1.54, p-value = 0.851).

Conclusion: IABP may be associated with longer ICU and hospital stays but not better short-and long-term clinical prognosis.

Citing Articles

A multivariate and retrospective analysis of the impact of intra-aortic balloon counterpulsation in Open-Heart surgery.

Sharma S, Nah J, Siddarth V, Lai H, Liang S, Ong Z Sci Rep. 2024; 14(1):29534.

PMID: 39604501 PMC: 11603185. DOI: 10.1038/s41598-024-81056-z.

Efficacy and safety of extracorporeal membrane oxygenation for cardiogenic shock complicating myocardial infarction: a systematic review and meta-analysis.

Elsaeidy A, Mohamed Taha A, Abuelazm M, Soliman Y, Ali M, Alassiri A BMC Cardiovasc Disord. 2024; 24(1):362.

PMID: 39014315 PMC: 11251331. DOI: 10.1186/s12872-024-03917-9.

References

Unverzagt S, Buerke M, de Waha A, Haerting J, Pietzner D, Seyfarth M . Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock. Cochrane Database Syst Rev. 2015; (3):CD007398. PMC: 8454261. DOI: 10.1002/14651858.CD007398.pub3. View

Karami M, Eriksen E, Ouweneel D, Claessen B, Vis M, Baan J . Long-term 5-year outcome of the randomized IMPRESS in severe shock trial: percutaneous mechanical circulatory support vs. intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2021; 10(9):1009-1015. PMC: 8648392. DOI: 10.1093/ehjacc/zuab060. View

Sloth E, Sprogoe P, Lindskov C, Horlyck A, Solvig J, Jakobsen C . Intra-aortic balloon pumping increases renal blood flow in patients with low left ventricular ejection fraction. Perfusion. 2009; 23(4):223-6. DOI: 10.1177/0267659108100457. View

Vallabhajosyula S, Verghese D, Henry T, Katz J, Nicholson W, A Jaber W . Contemporary Management of Concomitant Cardiac Arrest and Cardiogenic Shock Complicating Myocardial Infarction. Mayo Clin Proc. 2022; 97(12):2333-2354. DOI: 10.1016/j.mayocp.2022.06.027. View

Neumann F, Sousa-Uva M, Ahlsson A, Alfonso F, Banning A, Benedetto U . 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2018; 40(2):87-165. DOI: 10.1093/eurheartj/ehy394. View

Patel M, Smalling R, Thiele H, Barnhart H, Zhou Y, Chandra P . Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial. JAMA. 2011; 306(12):1329-37. DOI: 10.1001/jama.2011.1280. View

Thiele H, Zeymer U, Neumann F, Ferenc M, Olbrich H, Hausleiter J . Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet. 2013; 382(9905):1638-45. DOI: 10.1016/S0140-6736(13)61783-3. View

Ohman E, Nanas J, Stomel R, Leesar M, Nielsen D, ODea D . Thrombolysis and counterpulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: results of the TACTICS Trial. J Thromb Thrombolysis. 2005; 19(1):33-9. DOI: 10.1007/s11239-005-0938-0. View

Perera D, Stables R, Thomas M, Booth J, Pitt M, Blackman D . Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial. JAMA. 2010; 304(8):867-74. DOI: 10.1001/jama.2010.1190. View

10.

Antman E, Anbe D, Armstrong P, Bates E, Green L, Hand M . ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise.... Circulation. 2004; 110(5):588-636. DOI: 10.1161/01.CIR.0000134791.68010.FA. View

11.

Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T . Guidelines on myocardial revascularization. Eur Heart J. 2010; 31(20):2501-55. DOI: 10.1093/eurheartj/ehq277. View

12.

Bochaton T, Huot L, Elbaz M, Delmas C, Aissaoui N, Farhat F . Mechanical circulatory support with the Impella® LP5.0 pump and an intra-aortic balloon pump for cardiogenic shock in acute myocardial infarction: The IMPELLA-STIC randomized study. Arch Cardiovasc Dis. 2019; 113(4):237-243. DOI: 10.1016/j.acvd.2019.10.005. View

13.

Bendjelid K . IABP and cardiogenic shock: A heartbreaking story. Am Heart J. 2018; 199:178-180. DOI: 10.1016/j.ahj.2017.12.009. View

14.

Thiele H, Akin I, Sandri M, Fuernau G, de Waha S, Meyer-Saraei R . PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock. N Engl J Med. 2017; 377(25):2419-2432. DOI: 10.1056/NEJMoa1710261. View

15.

Prondzinsky R, Lemm H, Swyter M, Wegener N, Unverzagt S, Carter J . Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome. Crit Care Med. 2009; 38(1):152-60. DOI: 10.1097/CCM.0b013e3181b78671. View

16.

Zeng P, Yang C, Chen J, Fan Z, Cai W, Huang Y . Comparison of the Efficacy of ECMO With or Without IABP in Patients With Cardiogenic Shock: A Meta-Analysis. Front Cardiovasc Med. 2022; 9:917610. PMC: 9300857. DOI: 10.3389/fcvm.2022.917610. View

17.

Ouweneel D, Eriksen E, Sjauw K, van Dongen I, Hirsch A, Packer E . Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction. J Am Coll Cardiol. 2016; 69(3):278-287. DOI: 10.1016/j.jacc.2016.10.022. View

18.

Johnson A, Bulgarelli L, Shen L, Gayles A, Shammout A, Horng S . MIMIC-IV, a freely accessible electronic health record dataset. Sci Data. 2023; 10(1):1. PMC: 9810617. DOI: 10.1038/s41597-022-01899-x. View

19.

Tie E, Dinh D, Chan W, Clark D, Ajani A, Brennan A . Trends in Intra-Aortic Balloon Pump Use in Cardiogenic Shock After the SHOCK-II Trial. Am J Cardiol. 2023; 191:125-132. DOI: 10.1016/j.amjcard.2022.12.019. View

20.

Prondzinsky R, Unverzagt S, Russ M, Lemm H, Swyter M, Wegener N . Hemodynamic effects of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP shock trial. Shock. 2012; 37(4):378-84. DOI: 10.1097/SHK.0b013e31824a67af. View